🟢 CalciMedica is trading 6.65% up in after-hours trading after Guggenheim's Buy initiation

CalciMedica is trading 6.65% up at $0.62 after Guggenheim initiated coverage on August 20, 2026, with a Buy rating and a $9.00 price target.

• The positive analyst action appears to be supporting the after-hours rebound.
• The regular session declined following shareholder approval of a potential 1-for-2 to 1-for-10 reverse split.
• After-hours activity is elevated relative to the regular-session move, reversing from a $0.58 close.